These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Isotretinoin and pregnancy prevention: do we need to take a long, hard look at ourselves? Altman EM JAMA Dermatol; 2014 Apr; 150(4):361-2. PubMed ID: 24258339 [No Abstract] [Full Text] [Related]
24. Possible association between isotretinoin and inflammatory bowel disease. Reddy D; Siegel CA; Sands BE; Kane S Am J Gastroenterol; 2006 Jul; 101(7):1569-73. PubMed ID: 16863562 [TBL] [Abstract][Full Text] [Related]
25. Isotretinoin and inflammatory bowel disease. Rolanda C; Macedo G Am J Gastroenterol; 2007 Jun; 102(6):1330. PubMed ID: 17531023 [No Abstract] [Full Text] [Related]
27. Isotretinoin and iPledge: a view of results. Maloney ME; Stone SP J Am Acad Dermatol; 2011 Aug; 65(2):418-419. PubMed ID: 21763564 [No Abstract] [Full Text] [Related]
28. [Isotretinoin does not increase the risk of intestinal inflammatory disease]. Pariente A Rev Prat; 2014 Jun; 64(6):769. PubMed ID: 25090755 [No Abstract] [Full Text] [Related]
29. Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease. Margolis DJ; Fanelli M; Hoffstad O; Lewis JD Am J Gastroenterol; 2010 Dec; 105(12):2610-6. PubMed ID: 20700115 [TBL] [Abstract][Full Text] [Related]
30. Isotretinoin and inflammatory bowel disease: trial lawyer misuse of science and FDA warnings. Tenner S Am J Gastroenterol; 2014 Apr; 109(4):570-1. PubMed ID: 24698863 [TBL] [Abstract][Full Text] [Related]
31. A call for action--prevention of fetal exposure to isotretinoin. A position paper by The Organization of Teratology Information Services Public Affairs Committee. Carver V; Coyle B; Koren G; Lavigne S; Martinez L; Robertson J; Polifka J; Stepanuk K; Reprod Toxicol; 2001; 15(6):729. PubMed ID: 11738527 [No Abstract] [Full Text] [Related]
33. Family physicians and accutane. Van Durme DJ Am Fam Physician; 2000 Oct; 62(8):1772, 1774, 1777. PubMed ID: 11057835 [No Abstract] [Full Text] [Related]
34. Accutane registry compulsory in US, but not Canada. Andresen M CMAJ; 2006 Jun; 174(12):1701. PubMed ID: 16754892 [No Abstract] [Full Text] [Related]
35. Isotretinoin and risk for inflammatory bowel disease: a nested case-control study and meta-analysis of published and unpublished data. Etminan M; Bird ST; Delaney JA; Bressler B; Brophy JM JAMA Dermatol; 2013 Feb; 149(2):216-20. PubMed ID: 23426479 [TBL] [Abstract][Full Text] [Related]
36. REMS review explores programs' burdens. Traynor K Am J Health Syst Pharm; 2012 Jan; 69(2):92, 94. PubMed ID: 22215349 [No Abstract] [Full Text] [Related]
37. Eruptive milia during isotretinoin therapy. Farmer W; Cheng K; Marathe K Pediatr Dermatol; 2017 Nov; 34(6):728-729. PubMed ID: 28940619 [TBL] [Abstract][Full Text] [Related]